Qube Research & Technologies LTD Geron Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Geron Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 375,395 shares of GERN stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
375,395Holding current value
$1.78 Million% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding GERN
# of Institutions
257Shares Held
448MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$221 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$219 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$151 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$129 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$113 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.79B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...